WallStreetZenWallStreetZen

NASDAQ: VVOS
Vivos Therapeutics Inc Stock

$2.24-0.05 (-2.18%)
Updated May 20, 2024
VVOS Price
$2.24
Fair Value Price
N/A
Market Cap
$7.23M
52 Week Low
$1.96
52 Week High
$48.79
P/E
-0.2x
P/B
12.42x
P/S
0.83x
PEG
N/A
Dividend Yield
N/A
Revenue
$13.36M
Earnings
-$15.64M
Gross Margin
58.9%
Operating Margin
-117.06%
Profit Margin
-117.1%
Debt to Equity
19.28
Operating Cash Flow
-$11M
Beta
0.88
Next Earnings
Jun 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

VVOS Overview

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VVOS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VVOS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VVOS is poor value based on its book value relative to its share price (12.42x), compared to the US Medical Devices industry average (3.98x)
P/B vs Industry Valuation
VVOS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more VVOS due diligence checks available for Premium users.

Be the first to know about important VVOS news, forecast changes, insider trades & much more!

VVOS News

Valuation

VVOS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.2x
Industry
30.55x
Market
31.12x

VVOS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
12.42x
Industry
3.98x
VVOS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VVOS's financial health

Profit margin

Revenue
$3.4M
Net Income
-$3.8M
Profit Margin
-110.1%
VVOS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VVOS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.8M
Liabilities
$11.2M
Debt to equity
19.28
VVOS's short-term liabilities ($8.07M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VVOS's short-term assets ($3.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VVOS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.5M
Investing
-$151.0k
Financing
$3.6M
VVOS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VVOS vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
VVOS$7.23M-2.18%-0.20x12.42x
TBIO$7.59M+0.22%-0.16x-0.92x
INBS$7.64M+8.89%-0.06x0.69x
NURO$8.01M-1.58%-0.64x0.43x
AIMD$6.28M-3.85%-0.30x0.28x

Vivos Therapeutics Stock FAQ

What is Vivos Therapeutics's quote symbol?

(NASDAQ: VVOS) Vivos Therapeutics trades on the NASDAQ under the ticker symbol VVOS. Vivos Therapeutics stock quotes can also be displayed as NASDAQ: VVOS.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.

What is the 52 week high and low for Vivos Therapeutics (NASDAQ: VVOS)?

(NASDAQ: VVOS) Vivos Therapeutics's 52-week high was $48.79, and its 52-week low was $1.96. It is currently -95.41% from its 52-week high and 14.29% from its 52-week low.

How much is Vivos Therapeutics stock worth today?

(NASDAQ: VVOS) Vivos Therapeutics currently has 3,227,270 outstanding shares. With Vivos Therapeutics stock trading at $2.24 per share, the total value of Vivos Therapeutics stock (market capitalization) is $7.23M.

Vivos Therapeutics stock was originally listed at a price of $224.75 in Dec 11, 2020. If you had invested in Vivos Therapeutics stock at $224.75, your return over the last 3 years would have been -99%, for an annualized return of -78.48% (not including any dividends or dividend reinvestments).

How much is Vivos Therapeutics's stock price per share?

(NASDAQ: VVOS) Vivos Therapeutics stock price per share is $2.24 today (as of May 20, 2024).

What is Vivos Therapeutics's Market Cap?

(NASDAQ: VVOS) Vivos Therapeutics's market cap is $7.23M, as of May 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vivos Therapeutics's market cap is calculated by multiplying VVOS's current stock price of $2.24 by VVOS's total outstanding shares of 3,227,270.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.